EMM (drug)
Pharmaceutical compound
From Wikipedia, the free encyclopedia
EMM, also known as 2-ethoxy-4,5-dimethoxyamphetamine or as TMA2-2-EtO, is a chemical compound of the phenethylamine, amphetamine, and DOx families related to the psychedelic drug TMA-2.[1][2][3] It is the analogue of TMA-2 in which the methoxy group at the 2 position has been replaced with an ethoxy group.[1][2][3] In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists EMM's dose as greater than 50 mg orally and its duration as unknown.[1][2][3] The drug produced no effects at doses of up to 50 mg.[1][2] Higher doses were not tested.[1][2][3] The chemical synthesis of EMM has been described.[1][4] EMM was first described in the scientific literature by Shulgin in 1968.[4] Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991.[1]
 | |
| Clinical data | |
|---|---|
| Other names | 2-Ethoxy-4,5-dimethoxyamphetamine; TMA2-2-EtO |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H21NO3 |
| Molar mass | 239.315 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
